Anixa Biosciences (ANIX) FCF Margin (QoQ) (2011 - 2018)
Anixa Biosciences (ANIX) FCF Margin (QoQ) (2011 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | Anixa Biosciences | 124.96 Mn | 124.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2018 | -22,804.00 |
| Oct 31, 2016 | 47,579.00 |
| Jul 31, 2015 | 637,118.00 |
| Apr 30, 2015 | -716,735.00 |
| Jan 31, 2015 | 7,667.00 |
| Oct 31, 2014 | 208.00 |
| Oct 31, 2012 | -27.47 Mn |
| Jul 31, 2012 | 10,821.00 |
| Apr 30, 2012 | -21,362.00 |
| Jan 31, 2012 | 1,219.00 |
| Oct 31, 2011 | -45,438.00 |
| Jul 31, 2011 | 113,360.00 |
| Apr 30, 2011 | 279,396.00 |
| Jan 31, 2011 | -346,573.00 |